Journal
BIPOLAR DISORDERS
Volume 3, Issue 4, Pages 189-201Publisher
MUNKSGAARD INT PUBL LTD
DOI: 10.1034/j.1399-5618.2001.30404.x
Keywords
affective disorders; lipid metabolism; lithium; membrane; myo-inositol; phosphatidylinositol cycle
Categories
Funding
- NIA NIH HHS [AG018974] Funding Source: Medline
Ask authors/readers for more resources
Objective: There is evidence linking affective disorders and their treatment to alterations in membrane phospholipid metabolism, the phosphatidylinositol (PtdIns) second messenger cycle and brain excitatory and inhibitory amino acids. This study examines lithium effects on rat brain metabolites associated with the above systems and their reversal by myo-inositol. Methods: Thirty rats were treated for 14 days with i.p. lithium, saline or lithium plus inyo-inositol. H-1, P-31 and Li-7 NMR were used to measure brain metabolites. Results: Lithium, administered alone or with inyo-inositol, resulted in brain lithium concentrations of approximately 0.6 muM/gram brain tissue. Brain myo-inositol was unchanged when lithium was co-administered with myo-inositol. Lithium increased brain inositol-1-phosphate (I1P) by 98% compared with saline and this effect was not attenuated by the addition of myo-inositol. Lithium treatment decreased phosphatidylserine (PtdSer) and PtdIns by 3% and 8%. respectively. Lithium also decreased taurine levels by 8% and increased aspartate levels by 9%. The above effects of lithium on PtdSer, PtdIns and taurine were attenuated or abolished by the co-administration of myo-inositol. Conclusions: Lithium alters levels of key membrane phospholipids and appears to affect the balance between inhibitory and excitatory amino acids in rat brain. Co-administration of myo-inositol attenuates some of these lithium effects on brain metabolites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available